Document is current
Any future updates will be listed below
-
Authors
Van Laethem, Delphine https://orcid.org/0000-0001-8341-2761
Van de Steen, Frederik
Kos, Daphne
Naeyaert, Maarten
Van Schuerbeek, Peter
D’Haeseleer, Miguel
D’Hooghe, Marie B.
Van Schependom, Jeroen
Nagels, Guy
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (1SD5322N, 1267422N, 1805620N)
- License Information
-
More Information
Article History
Received: 5 July 2022
Accepted: 27 August 2022
First Online: 14 September 2022
Declarations
:
: This study was approved by the ethics committees of the Universitair Ziekenhuis Brussel and the National Multiple Sclerosis Center Melsbroek. Written informed consent to participate will be obtained from all participants by the investigators carrying out the testing. If patients are included in ancillary studies for which additional data needs to be collected, additional informed consent will be obtained.Any modifications to the protocol will require a formal amendment to the protocol, which will be submitted to both ethical committees. Any unanticipated and/or serious adverse events that are classed as related and unexpected will be reported to the ethics committee.
: N/A.
: The authors declare no competing interests.
